47 related articles for article (PubMed ID: 23237063)
1. TGFB1 mRNA expression and frequency of the + 869T>C and + 915G>C genetic variants: impact on risk for systemic sclerosis.
Lomeli-Nieto JA; Muñoz-Valle JF; Navarro-Zarza JE; Baños-Hernández CJ; García-Arellano S; Alvarado-Navarro A; Anaya-Macías BU; Oregón-Romero E; Fuentes-Baez CE; Parra-Rojas I; Hernández-Bello J
Clin Exp Med; 2023 Aug; 23(4):1349-1357. PubMed ID: 36464760
[TBL] [Abstract][Full Text] [Related]
2. Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study.
Kosałka-Węgiel J; Lichołai S; Pacholczak-Madej R; Dziedzina S; Milewski M; Kuszmiersz P; Korona A; Gąsior J; Matyja-Bednarczyk A; Kwiatkowska H; Zaręba L; Siwiec-Koźlik A; Koźlik-Siwiec P; Wach A; Pociej-Marciak W; Sanak M; Musiał J; Bazan-Socha S; Korkosz M
Rheumatol Int; 2024 Jan; 44(1):119-128. PubMed ID: 38051374
[TBL] [Abstract][Full Text] [Related]
3. Oral
Melchiorre D; Ceccherini MT; Romano E; Cometi L; El-Aoufy K; Bellando-Randone S; Roccotelli A; Bruni C; Moggi-Pignone A; Carboni D; Guiducci S; Lepri G; Tofani L; Pietramellara G; Matucci-Cerinic M
Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34203626
[TBL] [Abstract][Full Text] [Related]
4. Distinct molecular subtypes of systemic sclerosis and gene signature with diagnostic capability.
Wang Q; Li CL; Wu L; Hu JY; Yu Q; Zhang SX; He PF
Front Immunol; 2023; 14():1257802. PubMed ID: 37849750
[TBL] [Abstract][Full Text] [Related]
5. ADAR1 promotes systemic sclerosis
Sun C; Cai D; Chen SY
Front Immunol; 2022; 13():1051254. PubMed ID: 36532023
[TBL] [Abstract][Full Text] [Related]
6. Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma Patients.
Makinde HM; Dunn JLM; Gadhvi G; Carns M; Aren K; Chung AH; Muhammad LN; Song J; Cuda CM; Dominguez S; Pandolfino JE; Dematte D'Amico JE; Budinger GS; Assassi S; Frech TM; Khanna D; Shaeffer A; Perlman H; Hinchcliff M; Winter DR
Arthritis Rheumatol; 2023 Apr; 75(4):595-608. PubMed ID: 36281773
[TBL] [Abstract][Full Text] [Related]
7. Association of GTF2I, NFKB1, and TYK2 Regional Polymorphisms With Systemic Sclerosis in a Chinese Han Population.
Liu C; Yan S; Chen H; Wu Z; Li L; Cheng L; Li H; Li Y
Front Immunol; 2021; 12():640083. PubMed ID: 34248934
[TBL] [Abstract][Full Text] [Related]
8. Genetic Susceptibility to Systemic Sclerosis in the Greek-Cypriot Population: A Pilot Study.
Chairta P; Psarelis S; Michailidou K; Demetriou C; Symeonidou S; Nicolaou P; Christodoulou K
Genet Test Mol Biomarkers; 2020 May; 24(5):309-317. PubMed ID: 32315557
[No Abstract] [Full Text] [Related]
9. Genetic association between NFKB1 -94 ins/del ATTG Promoter Polymorphism and cancer risk: a meta-analysis of 42 case-control studies.
Wang D; Xie T; Xu J; Wang H; Zeng W; Rao S; Zhou K; Pei F; Zhou Z
Sci Rep; 2016 Jul; 6():30220. PubMed ID: 27443693
[TBL] [Abstract][Full Text] [Related]
10. Influence of Genetic Ancestry on INDEL Markers of NFKβ1, CASP8, PAR1, IL4 and CYP19A1 Genes in Leprosy Patients.
Pinto P; Salgado C; Santos NP; Santos S; Ribeiro-dos-Santos Â
PLoS Negl Trop Dis; 2015; 9(9):e0004050. PubMed ID: 26367014
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures.
Taroni JN; Martyanov V; Huang CC; Mahoney JM; Hirano I; Shetuni B; Yang GY; Brenner D; Jung B; Wood TA; Bhattacharyya S; Almagor O; Lee J; Sirajuddin A; Varga J; Chang RW; Whitfield ML; Hinchcliff M
Arthritis Res Ther; 2015 Jul; 17():194. PubMed ID: 26220546
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of Systemic Sclerosis.
Pattanaik D; Brown M; Postlethwaite BC; Postlethwaite AE
Front Immunol; 2015; 6():272. PubMed ID: 26106387
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of NFκB1 -94 del/ins ATTG, NFκB1A 2758 A>G and SUMO rs237025 G>A in psoriasis.
Alzolibani AA; Settin A; Ahmed AA; Ismail H; Elhefni N; Al Robaee AA
Int J Health Sci (Qassim); 2015 Jan; 9(1):25-33. PubMed ID: 25901130
[TBL] [Abstract][Full Text] [Related]
14. Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis.
Huang XL; Wang YJ; Yan JW; Wan YN; Chen B; Li BZ; Yang GJ; Wang J
Inflamm Res; 2015 Apr; 64(3-4):151-9. PubMed ID: 25725697
[TBL] [Abstract][Full Text] [Related]
15. Systemic Sclerosis is a Complex Disease Associated Mainly with Immune Regulatory and Inflammatory Genes.
Jin J; Chou C; Lima M; Zhou D; Zhou X
Open Rheumatol J; 2014; 8():29-42. PubMed ID: 25328554
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer.
Nian X; Zhang W; Li L; Sun Y; Sun E; Han R
Tumour Biol; 2014 Dec; 35(12):11921-31. PubMed ID: 25190017
[TBL] [Abstract][Full Text] [Related]
17. Investigation of NF-κB1 and NF-κBIA gene polymorphism in non-small cell lung cancer.
Oltulu YM; Coskunpinar E; Ozkan G; Aynaci E; Yildiz P; Isbir T; Yaylim I
Biomed Res Int; 2014; 2014():530381. PubMed ID: 24707489
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic mechanisms of chronic urticaria.
Losol P; Yoo HS; Park HS
Allergy Asthma Immunol Res; 2014 Jan; 6(1):13-21. PubMed ID: 24404388
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 gene promoter and NFKB1 promoter insertion/deletion polymorphisms in systemic sclerosis.
Salim PH; Jobim M; Bredemeier M; Chies JA; Brenol JC; Jobim LF; Xavier RM
Scand J Immunol; 2013 Feb; 77(2):162-8. PubMed ID: 23237063
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
